Globus Medical (GMED) Raw Materials (2018 - 2025)

Globus Medical's Raw Materials history runs 8 years deep, the most recent figure standing at $152.1 million for Q3 2025.

• Quarterly Raw Materials rose 31.33% year-over-year to $152.1 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $152.1 million (up 31.33% YoY) and the FY2024 annual result came in at $122.0 million, up 18.03% from the prior year.
• Raw Materials was $152.1 million for Q3 2025 at Globus Medical, down from $153.3 million in the prior quarter.
• Across five years, Raw Materials topped out at $153.3 million in Q2 2025 and bottomed at $41.7 million in Q1 2021.
• A 5-year average of $84.8 million and a median of $75.0 million in 2023 frame the typical range for Raw Materials.
• Annual changes were most pronounced in 2021 — Raw Materials increased 5.48% — and 2023, when it surged 71.32%.
• Globus Medical's Raw Materials stood at $41.8 million in 2021, then jumped by 44.25% to $60.3 million in 2022, then jumped by 71.32% to $103.3 million in 2023, then gained by 18.03% to $122.0 million in 2024, then gained by 24.71% to $152.1 million in 2025.
• Business Quant data shows GMED's Raw Materials at $152.1 million in Q3 2025, $153.3 million in Q2 2025, and $118.6 million in Q1 2025.